Julphar launches MEBO Scar to Middle East pharmaceutical market
- United Arab Emirates: Sunday, March 04 - 2012 at 14:19
- PRESS RELEASE
Julphar (Gulf Pharmaceutical Industries) has launched the latest in cosmetic scar restoration products to the Middle East. MEBO Scar ointment was developed specifically by Julphar for the treatment of scars both old and new, and is used to restore the health of traumatized skin.
Professor Chen Yongchen, the Clinical Director of China National & Technology Centre for Burns, Wounds and Ulcers and Dr Shu Ye, Product Instructor/Technical Support Manager travelled from China to be part of the launch initiative.
Addressing specialist physicians across the region Dr She Yu said, "MEBO Scar is made of pure, natural components which ensure sufficient elasticity and strength of the scar tissue, achieving optimum cosmetic results". Professor Chen Yongchen added, "The launch of Mebo Scar will help Dermatologists, Plastic Surgeons, Gynecologists and other Physicians, in the treatment and restoration of scars."
Cosmetic scar therapy is a lucrative business worldwide and MEBO Scar follows the success of MEBO, a widely distributed wound healing product. The release of MEBO Scar will help patients with both functional and cosmetic problems caused by scarring and improve their quality of life.
Articles in this section are primarily provided directly by the companies appearing or PR agencies which are solely responsible for the content. The companies concerned may use the above content on their respective web sites provided they link back to http://www.ameinfo.com
Any opinions, advice, statements, offers or other information expressed in this section of the AMEinfo.com Web site are those of the authors and do not necessarily reflect the views of Mediaquest FZ LLC. Mediaquest FZ LLC is not responsible or liable for the content, accuracy or reliability of any material, advice, opinion or statement in this section of the AMEinfo.com Web site.